Search
for
Sort by
Research 361–390 of 1000+
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- Umbilical Cord Mesenchymal Stromal Cell-Derived Exosomes Rescue the Loss of Outer Hair Cells and Repair Cochlear Damage in Cisplatin-Injected Mice
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Alopecia Areata Update
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Interventions for female pattern hair loss
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Hair loss
- Hair loss
- Stem Cell Applications in Human Hair Growth: A Literature Review
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Hair Follicle Targeting with Nanoparticles
- <i>In vivo</i> and <i>in silico</i> evaluation of the ameliorative effect of hesperidin on finasteride-induced testicular oxidative stress in Wistar rats
- Current systemic treatment strategies for hidradenitis suppurativa
- Telogen effluvium treated with Serenoa repens supplement
- Effects of local and systemic medications on eye health: Adverse reactions
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Innovative Uses for Zinc in Dermatology
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cutaneous Reactions to Drugs
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane